Inventor
James M. Salovich
Inventor
Nashville, TN, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
10,807,959WDR5-MLL1 inhibitors and modulators202010,501,421Substituted benzimidazoles as modulators of Ras signaling201910,501,466WDR5 inhibitors and modulators20199,868,746'Substituted 5-aminothieno[2,3-C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4'20189,493,481'Substituted 5-aminothieno[2,3—C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4'20169,192,603'Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction'20159,163,015'Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction'20159,108,963'Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction'20159,056,876'Substituted 1H-pyrazolo[3′,4′,4,5]thieno[2,3-b]pyridin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4'20159,056,875'Substituted pyrazolo[3′,4′:4,5]thieno[2,3-C]pyridazin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4'20158,779,157'MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction'20148,093,239'Imidazopyridine kinase inhibitors'20127,786,127'Benzimidazole thiophene compounds'20107,595,330'Benzimidazole thiophene compounds'20097,514,446'Pyrimidine compounds'20097,462,614'Imidazotriazine compounds'20085,326,760'Aminobutanoic acid compounds having metalloprotease inhibiting properties'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994Based in Cary, NC, US· patent location history
2008–2012Based in Durham, NC, US· patent location history
2012–2015Patents assigned to SALOVICH JAMES M (5)· patent assignee history
2014–2020Patents assigned to UNIV VANDERBILT (11)· patent assignee history
2014–2015Patents assigned to CHEUNG YIU-YIN (4)· patent assignee history
2014–2015Patents assigned to CONN P JEFFREY (4)· patent assignee history
2014–2015Patents assigned to ENGERS DARREN W (4)· patent assignee history
2014–2020Based in Nashville, TN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV VANDERBILT | 11 | 2014–2020 |
| SALOVICH JAMES Mself | 5 | 2012–2015 |
| CHEUNG YIU-YIN | 4 | 2014–2015 |
| CONN P JEFFREY | 4 | 2014–2015 |
| ENGERS DARREN W | 4 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Nashville, TN, US | 11 | 2014–2020 |
| Durham, NC, US | 5 | 2008–2012 |
| Cary, NC, US | 1 | 1994 |